Health care workers push for their own confidential mental health treatment

States are redefining when medical professionals can get mental health treatment without risking notifying the boards that regulate their licenses.

HUC-3443 by Huons for Hypercholesterolemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 4, 2023

Notes from the International Society for Research on Psychedelics’ 2024 Conference in New Orleans (Guest Contribution) – Psychedelic Alpha

Pre-clinical/Basic Sciences To start off the conference, Dr. Kevin Murnane, Associate Professor at Louisiana State University (LSU) Health Sciences Center Shreveport, presented parallel research on

March 20, 2024

Late-night REM sleep loss severely impacts brain connectivity, new study reveals

Research reveals that REM sleep deprivation disrupts brain connectivity, with the thalamus playing a key role in sensory information relay and REM sleep regulation.

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.